Metabolomic profiling to improve glomerular filtration rate estimation: A proof-of-concept study

Nephrology Dialysis Transplantation

Volumn 34, Issue 5, 2019, Pages 825-833

  Coresh, Josef ^a   Inker, Lesley A ^b   Sang, Yingying ^a   Chen, Jingsha ^a   Shafi, Tariq ^a   Post, Wendy S ^a   Shlipak, Michael G ^c   Ford, Lisa ^d   Goodman, Kelli ^d   Perichon, Regis ^d   Greene, Tom ^e   Levey, Andrew S ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d METABOLON INC   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Creatinine; Estimating equations; GFR; Kidney function; Metabolomics

Indexed keywords

CREATININE; CYSTATIN C; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BIOASSAY; COHORT ANALYSIS; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; METABOLIC FINGERPRINTING; PRIORITY JOURNAL; RATING SCALE; VALIDATION PROCESS; VALIDITY; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; GLOMERULUS FILTRATION RATE; LIQUID CHROMATOGRAPHY; METABOLOMICS; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROOF OF CONCEPT; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CHROMATOGRAPHY, LIQUID; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; PROOF OF CONCEPT STUDY; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS;

EID: 85047983485     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfy094     Document Type: Article

References (23)

1. Levin A, Stevens PE, Bilous RW et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1–150
2. Stevens LA, Coresh J, Greene T et al. Assessing kidney function–measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473–2483
3. Horio M, Imai E, Yasuda Y et al. Performance of GFR equations in Japanese subjects. Clin Exp Nephrol 2013; 17: 352–358
4. Jessani S, Levey AS, Bux R et al. Estimation of GFR in South Asians: a study from the general population in Pakistan. Am J Kidney Dis 2014; 63: 49–58
5. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612
6. Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA 2015; 313: 837–846
7. Ballew SH, Chen Y, Daya NR et al. Frailty, kidney function, and polyphar-macy: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 2017; 69: 228–236
8. Inker LA, Schmid CH, Tighiouart H et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20–29
9. Sekula P, Goek ON, Quaye L et al. A metabolome-wide association study of kidney function and disease in the general population. J Am Soc Nephrol 2016; 27: 1175–1188
10. Goek ON, Doring A, Gieger C et al. Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis 2012; 60: 197–206
11. Goek ON, Prehn C, Sekula P et al. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrol Dial Transplant 2013; 28: 2131–2138
12. Rhee EP, Clish CB, Ghorbani A et al. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol 2013; 24: 1330–1338
13. Niewczas MA, Sirich TL, Mathew AV et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int 2014; 85: 1214–1224
14. Yu B, Zheng Y, Nettleton JA et al. Serum metabolomic profiling and incident CKD among African Americans. Clin J Am Soc Nephrol 2014; 9: 1410–1417
15. Evans AM, DeHaven CD, Barrett T et al. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009; 81: 6656–6667
16. Evans AM, Bridgewater BR, Liu Q et al. High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics. Metabolomics 2014; 4: 132
17. Inker LA, Shafi T, Okparavero A et al. Effects of race and sex on measured GFR: the multi-ethnic study of atherosclerosis. Am J Kidney Dis 2016; 68: 743–751
18. Kwong YT, Stevens LA, Selvin E et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis 2010; 56: 39–49
19. Schefold JC, Zeden JP, Fotopoulou C et al. Increased indoleamine 2, 3-diox-ygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant 2009; 24: 1901–1908
20. Kottgen A, Glazer NL, Dehghan A et al. Multiple loci associated with indi-ces of renal function and chronic kidney disease. Nat Genet 2009; 41: 712–717
21. O’Seaghdha CM, Tin A, Yang Q et al. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality. Am J Kidney Dis 2014; 63: 16–22
22. Rhee EP, Clish CB, Pierce KA et al. Metabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertension. J Hypertens 2015; 33: 836–842
23. Seegmiller JC, Burns BE, Schinstock CA et al. Discordance between iothalamate and iohexol urinary clearances. Am J Kidney Dis 2016; 67: 49–55